Serum Bone Biomarkers and Oral/Systemic Bone Loss in Humans

Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?

Background: The primary objective of this study was to assess BMD change in Iranian females with breast cancer. Methods: A sample of 73 female breast cancer patients treated with adjuvant chemotherapy either alone or followed by radiotherapy between March 2013 and February 2016 were considered for this study. Bone mineral density (BMD) change was evaluated by measuring z-score of lumbar spin...

adequate serum copper concentration could improve bone density, postpone bone loss and protect osteoporosis in women

background: to determine the protective impact of efficient serum copper concentration on bmd in women and to asses its impression on bone. methods: six hundred healthy women through a national project in iran, imos, were selected via a cluster random sam pling and enrolled the study. they were divided to pre menopausal (404/600, 67.7% of total) and post menopausal (190/600, 32%of total) groups...

changes in cytokines, biomarkers of bone turnover and hormones are associated with bone loss in postmenopausal indian women

Bone Mineral Density, Lean Body Mass and Bone Biomarkers Following Physical Exercise in Children with Acute Lymphoblastic Leukemia Undergoing Chemotherapy

Background: This study was aimed to evaluate the effects of physical exercise on bone mineral density (BMD), lean body mass (LBM) and bone biomarkers in children with acute lymphoblastic leukemia on chemotherapy. Methods: forty-six leukemic children were randomly assigned to two groups; exercise group (E) undergoing supervised mixed exercise program consisting of aerobic, resistance and flexib...

Serum ferritin levels and bone mineral density in the elderly

Background: Iron overload influences negatively on bone mineral density (BMD) but the results of studies regarding serum ferritin (SF) and BMD are conflicting.This study aimed to determine the association of SF and BMD in the elderly. Methods: All participants of the Amirkola cohort selected between 2011-2012, aged > 60 years were classified as high or normal (<200ng/ml) SF. BMD at femoral nec...